Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Economical simulations for the optimal use of anti-programmed cell death-1 in advanced melanoma patients: Report of a budget impact analysis

Published:2020-04-20 Issue:5 Volume:26 Page:1216-1219
ISSN:1078-1552
Container-title:Journal of Oncology Pharmacy Practice
language:en
Short-container-title:J Oncol Pharm Pract

Author:

Clarenne Justine¹,Boulanger Coralie¹,Maréchal Antonin¹,Visseaux Laëtitia²,Slimano Florian¹³^ORCID

Affiliation:

1. Department of Pharmacy, CHU Reims, Robert-Debré Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

2. Department of Dermatology, CHU Reims, Robert-Debré Hospital, Avenue du Général Koenig, 51092 Reims Cedex, France

3. Faculty of Pharmacy, Reims University, 51 rue Cognacq-Jay, 51100 Reims, France

Publisher

SAGE Publications

Subject

Pharmacology (medical),Oncology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1078155220918019

Reference18 articles.

1. Actualités dans la prévention et la prise en charge du mélanome : implications et enjeux pour le pharmacien

2. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

3. Pembrolizumab versus Ipilimumab in Advanced Melanoma

4. Survival Outcomes in Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma Treated With Nivolumab Therapy

5. Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosing of PD-1 and PD-L1 inhibitors: Cost saving initiatives for significantly decreasing associated expenditure;Journal of Oncology Pharmacy Practice;2020-11-20

2. Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective;Vaccines;2020-10-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3